| Katalin Galasi, PSYD | |
|
902 Curtis St, Albany, CA 94706-2108 | |
| (510) 594-4055 | |
| Not Available |
| Full Name | Katalin Galasi |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 902 Curtis St, Albany, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285799924 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PSY20445 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Katalin Galasi, PSYD 710 S Broadway, Walnut Creek, CA 94596-5294 Ph: (510) 295-3215 | Katalin Galasi, PSYD 902 Curtis St, Albany, CA 94706-2108 Ph: (510) 594-4055 |
News Archive
Using a yeast model of Alzheimer's disease (AD), Whitehead Institute researchers have identified a drug that reduces levels of the toxic protein fragment amyloid-β (Aβ) and prevents at least some of the cellular damage caused when Aβ accumulates in the brains of AD patients.
Fear of litigation and perceived safety concerns and are among the key factors influencing the decision to perform a cesarean section, according to a major international literature review conducted by researchers at the School of Nursing and Midwifery, Trinity College Dublin.
PreCision Dermatology Inc., a company focused on developing, manufacturing, acquiring and marketing a broad portfolio of innovative dermatology products, today announced it was formed as the result of the spin-out of Onset Therapeutics, a wholly-owned subsidiary of Collegium Pharmaceutical, Inc. PreCision Dermatology also announced the close of a Series A financing led by life science private equity investor Essex Woodlands.
BioSante Pharmaceuticals, Inc. today announced positive results of a human clinical study that show that its GVAX Leukemia vaccine may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia (CML) patients taking the drug Gleevec (imatinib mesylate).
The National Heart, Lung, and Blood Institute (NHLBI) has stopped a clinical trial evaluating a new approach to reduce the risk of recurrent stroke in children with sickle cell anemia and iron overload because of evidence that the new treatment was unlikely to prove better than the existing treatment.
› Verified 4 days ago
Dr. Lynn Winsten, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1664 Solano Ave, 12, Albany, CA 94707 Phone: 510-526-7066 | |
Dr. Rebecca Liora Soffer, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1035 San Pablo Ave Ste 5, Albany, CA 94706 Phone: 510-282-5710 | |
Dr. Kayoko Yokoyama, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 902 Curtis St, Albany, CA 94706 Phone: 510-516-0527 | |
Dr. Joan Stephanie Wenters, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1505 Solano Ave, Albany, CA 94707 Phone: 510-816-0772 | |
Dr. Adam Snider, PSYD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1201 Solano Ave # A&b, Albany, CA 94706 Phone: 424-239-9197 | |
Dr. Robyn Papathakis Shannon, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1035 San Pablo Ave, Albany, CA 94706 Phone: 415-237-0377 | |
Dr. Richele Howell, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1496 Solano Ave, Albany, CA 94706 Phone: 510-292-4088 |